Peter Libby and Team Reveal Causal Proteomic Links in Clonal Hematopoiesis
Peter Libby, Mallinckrodt Professor of Medicine and Cardiovascular Specialist at Harvard Medical School and Brigham and Women’s Hospital, posted on LinkedIn:
”Causal Proteomic Consequences of Clonal Hematopoiesis: Integrated Human Genetic and Murine Validation
Zhi Yu, Amelie Vromman…Art Schuermans…Thiago Rentz Ferreira Laginski… Abhishek Niroula…Michael C. Honigberg, Amy E. Lin …Sara Haidermota…Benjamin Ebert…Alexander G. Bick, Siddhartha Jaiswal, Robert E. Gerszten, Peter Libby, Rajat Gupta, Pradeep Natarajan
Presented elegantly today at AHA New Orleans by Zhi Yu, the results of an amazing collaboration on CHIP proteomics that provide new insights and generate novel mechanistic hypotheses regarding the manifold clinical consequences of this newly recognized risk factor.”
Stay updated with Hemostasis Today.
-
May 28, 2026, 12:57Ahmed Kardousha: Protecting Growth and Fertility in Transfusion-Dependent β-Thalassemia
-
May 28, 2026, 12:36Kabilan K L: Key Nursing Considerations for Abciximab Therapy
-
May 28, 2026, 12:17Astha Thakkar: Practical Approaches to Platelet Thresholds in ITP
-
May 28, 2026, 09:16Maxime Dely: The Human Connection Behind Stem Cell Donation
-
May 28, 2026, 09:15Heghine Khachatryan: Maternal Health Begins With Recognizing Iron Deficiency Early
-
May 28, 2026, 09:15Alejandro González Veliz: Why Cardiovascular Prevention Matters More Than Intervention
-
May 28, 2026, 05:29Kidist K.: First Balloon Pulmonary Angioplasty Performed as New CTEPH Program Launches
-
May 28, 2026, 04:59Maria Sol Andres: Exploring Lipid Disorders in Modern Cancer Care
-
May 28, 2026, 04:42Francesca Granata: Representing the Porphyria Community at the 79th World Health Assembly